研究：靶向突变NPM1的HLA-A*11:01限制性T细胞受体用于急性髓系白血病过继细胞治疗

原文标题：HLA-A*11:01-Restricted T Cell Receptors Targeting Mutant NPM1 for Adoptive Cell Therapy in Acute Myeloid Leukemia